Inventor · disambiguated record
Jingwu Duan
Also filed as: DUAN JINGWU
52 granted patents·4 pending applications·481 citations·filing 1997–2019
98Inventor score
Files withBRISTOL MYERS SQUIBB CO29BRISTOL MYERS SQUIBB PHARMA CO12DUAN JINGWU3DU PONT PHARM CO2WROBLESKI STEPHEN T2
Top patents by PatentIndex Score
56 records- 0197US6403632B1Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jun 11, 2002·78 cites·18 claims
- 0291US10335392B2Cyclic compounds useful as modulators of TNF αBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·5 cites·10 claims
- 0391US6495565B2β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 17, 2002·50 cites·70 claims
- 0490US9815859B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 14, 2017·11 cites·15 claims
- 0590US6906053B2Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jun 14, 2005·33 cites·24 claims
- 0690US6890915B2Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted May 10, 2005·32 cites·24 claims
- 0789US8586751B2Nicotinamide compounds useful as kinase modulatorsDE LUCCA GEORGE V·Filed 2010·Granted Nov 19, 2013·32 cites·10 claims
- 0888US8846673B2Azaindazoles as kinase inhibitors and use thereofDUAN JINGWU·Filed 2010·Granted Sep 30, 2014·20 cites·16 claims
- 0987US6740649B2Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 25, 2004·31 cites·49 claims
- 1087US6495548B1Lactam inhibitors of matrix metalloproteinases, TNF-α and aggrecanaseBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Dec 17, 2002·21 cites·20 claims
- 1186US10273259B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 30, 2019·4 cites·1 claims
- 1286US6376665B1Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanaseDU PONT PHARM CO·Filed 2000·Granted Apr 23, 2002·23 cites·23 claims
- 1385US7595317B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Sep 29, 2009·7 cites·14 claims
- 1482US9458171B2Pyrrolidinyl sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 4, 2016·4 cites·14 claims
- 1582US7888381B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 15, 2011·6 cites·6 claims
- 1682US6984648B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 10, 2006·15 cites·21 claims
- 1782US6743807B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 1, 2004·15 cites·42 claims
- 1881US7482372B2Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jan 27, 2009·4 cites·6 claims
- 1981US6689771B2Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanaseBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 10, 2004·14 cites·30 claims
- 2080US8034940B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 11, 2011·4 cites·11 claims
- 2179US6610731B2Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 26, 2003·8 cites·17 claims
- 2277US7294624B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 13, 2007·9 cites·14 claims
- 2371US6989139B2Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 24, 2006·5 cites·24 claims
- 2470US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 2569US6770647B2Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Aug 3, 2004·4 cites·15 claims
- 2668US10865191B2Heterocyclic compounds useful as modulators of TNF alphaBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 15, 2020·1 cites·4 claims
- 2768US10711020B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 2867US8324401B2Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofDUAN JINGWU·Filed 2009·Granted Dec 4, 2012·0 cites·10 claims
- 2964US6884806B2Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 26, 2005·2 cites·18 claims
- 3064US6057336ALactam metalloprotease inhibitorsDU PONT·Filed 1998·Granted May 2, 2000·22 cites·54 claims
- 3163US9771320B2Carbocyclic sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 26, 2017·1 cites·15 claims
- 3262US6720329B2Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA·Filed 2002·Granted Apr 13, 2004·1 cites·28 claims
- 3361US7592461B2Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 22, 2009·0 cites·6 claims
- 3461US6936620B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 30, 2005·1 cites·21 claims
- 3559US6620823B2Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB PHARME CO·Filed 2001·Granted Sep 16, 2003·3 cites·18 claims
- 3656US11078186B2ROR γ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 3, 2021·0 cites·4 claims
- 3753US2003225054A1Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agentsFiled 2003·Application pending·0 cites
- 3852US6962938B2Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Nov 8, 2005·0 cites·19 claims
- 3950US8304539B2Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofDUAN JINGWU·Filed 2009·Granted Nov 6, 2012·0 cites·19 claims
- 4050US6281352B1Macrocyclic compounds as metalloprotease inhibitorsDU PONT PHARM CO·Filed 1997·Granted Aug 28, 2001·10 cites·50 claims
- 4146US9663469B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·0 cites·6 claims
- 4245US9725443B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 8, 2017·0 cites·2 claims
- 4345US7625921B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 1, 2009·0 cites·14 claims
- 4445US7569689B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 4, 2009·0 cites·15 claims
- 4545US7132432B2Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 7, 2006·0 cites·15 claims
- 4643US7015217B2Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Mar 21, 2006·0 cites·15 claims
- 4742US10308652B2Tricyclic heterocyclic compounds useful as inhibitors of TNFBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 4, 2019·0 cites·3 claims
- 4841US2003212056A1Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)Filed 2002·Application pending·0 cites
- 4941US2004072802A1Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alphaFiled 2002·Application pending·0 cites
- 5041US2016326108A1Pyrrolidinyl sulfone derivatives and their use as ror gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →